Incidence of Otolaryngological Manifestations in Individuals with Autism Spectrum Disorder: A Special Focus on Auditory Disorders

by Soumil et al

 

Background

 

  • Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by stereotyped and repetitive behavior patterns.
  • Individuals with ASD often experience otolaryngological comorbidities, meaning they have additional conditions affecting the ear, nose, and throat.
  • This study aimed to investigate the prevalence of otolaryngological manifestations in individuals with ASD, with a particular focus on auditory disorders.

 

Methods

 

  • The study retrospectively reviewed the medical records of 142 children and adolescents diagnosed with ASD who were evaluated at the Hearing Research and Cochlear Implant Laboratory at the University of Miami Miller School of Medicine.
  • Data was collected on various otolaryngological conditions, including hearing loss, otitis media (middle ear infection), and sinusitis.
  • Auditory processing skills were assessed using standardized tests.

 

Results

 

  • The study found that 61% of individuals with ASD had at least one otolaryngological manifestation.
  • The most common otolaryngological conditions were hearing loss (35%), otitis media (16%), and sinusitis (10%).
  • Among those with hearing loss, conductive hearing loss (caused by problems in the outer or middle ear) was more common than sensorineural hearing loss (caused by damage to the inner ear).
  • Auditory processing disorders (APDs) were present in 26% of individuals with ASD.

 

Conclusions

 

  • This study highlights the high prevalence of otolaryngological comorbidities in individuals with ASD, particularly hearing loss and APDs.
  • Early identification and management of these conditions is important for optimizing outcomes in individuals with ASD.
  • Further research is needed to understand the underlying mechanisms of otolaryngological comorbidities in ASD and to develop effective interventions.

 

Additional notes

 

  • The study is limited by its retrospective design and relatively small sample size.
  • More research is needed to confirm these findings and to determine the long-term impact of otolaryngological comorbidities on individuals with ASD.

 

FAQ

Q1. What are otolaryngological comorbidities?

 

Ans. Otolaryngological comorbidities are medical conditions that co-occur with ASD and affect the ear, nose, and throat. These comorbidities include hearing loss, auditory processing disorders, chronic and recurrent otitis media, and sinusitis.

 

Q2. What are the common otolaryngological comorbidities in individuals with ASD?

 

Ans. Common otolaryngological comorbidities in individuals with ASD include hearing loss, auditory processing disorders such as central auditory processing disorder (CAPD), chronic and recurrent otitis media, and sinusitis.

 

Q3. What is the prevalence of auditory disorders in individuals with ASD?

 

Ans. Individuals with ASD often have auditory disorders including hearing loss and auditory processing disorders such as central auditory processing disorder (CAPD).

 

Q4. What is the impact of otolaryngological comorbidities on the neurological functioning of individuals with ASD?

 

Ans. Otolaryngological comorbidities negatively impact the neurological functioning of individuals with ASD. They contribute to difficulty sleeping, which increases irritability and may further aggravate the core behavioral symptoms of autism. The higher rate of sinusitis in individuals with ASD also contributes to the worsening of the autism behavior phenotype.

 

Q5. What is the need for better collaboration between healthcare providers and otolaryngologists?

 

Ans. The high prevalence of otolaryngological comorbidities in individuals with ASD warrants better collaboration between healthcare providers and otolaryngologists with expertise in auditory, sleep, and sinus disorders to improve the quality of life of affected individuals and their families/caregivers.

 

Source:

https://www.mdpi.com/2039-4349/14/1/5

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top